[Retracted] Effect of Autoimmune Cell Therapy on Immune Cell Content in Patients with COPD: A Randomized Controlled Trial

Table 1

Inclusion and exclusion criteria and abort test standard.

Project
Inclusion criteria	after inhalation of bronchodilators, except for other diseases causing incomplete reversible airflow obstruction
	45-80 years old
	Patients without other major diseases, history of allergies, and genetic history
	Signed informed consent
Exclusion criteria	Patients with chronic cough and wheezing caused by tuberculosis, tumor, irritant gas allergy etc.
	Patients complicated with cardiovascular, liver, kidney, hematopoietic system, and other serious primary diseases
	Patients with abnormal behavior or mental illness
	Allergic people
	Patients with communication barriers
	Patients with acute aggravation within 3 months of treatment
	Suffer from other major diseases and were allergic to the drugs used in this study
	Patients without using the drug as prescribed
	Those whose efficacy or safety judgment was affected by incomplete data
Abort test standard	Patients with severe adverse reactions or special physiological changes
	Patients with life-threatening